Incidence of venous thromboembolism: A community-based study in western france. Epi-getbp study group. Groupe d'etude de la thrombose de bretagne occidentale, Thromb Haemost, vol.83, pp.657-660, 2000. ,
URL : https://hal.archives-ouvertes.fr/hal-00726218
« Venous Thromboembolism (VTE) in Europe. The Number of VTE Events and Associated Morbidity and Mortality, Thrombosis and Haemostasis, vol.98, issue.4, pp.756-764, 2007. ,
« Ruling Out Deep Venous Thrombosis in Primary Care ,
Idiopathic venous thromboembolic disease. risk factors for recurrence in 2006] », Archives des maladies du coeur et des vaisseaux 100, pp.133-138, 2007. ,
The Epidemiology of Venous Thromboembolism, Circulation, vol.107, issue.90231, pp.4-8, 2003. ,
DOI : 10.1161/01.CIR.0000078468.11849.66
physiopathologie et diagnostic des thromboses veineuses profondes des membres inférieurs, pp.87-90 ,
Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home, New England Journal of Medicine, vol.334, issue.11, pp.682-687, 1996. ,
DOI : 10.1056/NEJM199603143341102
« A Comparison of Low-molecular-weight Heparin Administered Primarily at Home with ,
« Comparison of Low-molecular-weight Heparin, Administered Primarily at Home, with ,
Administered in Hospital, and Subcutaneous Heparin, Administered at Home for Deepvein Thrombosis, Angiology, vol.50, issue.10, pp.781-787, 1999. ,
« [Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients], 127?136. 11 AFSSAPS. Recommandation de bonne pratique. Prévention et traitement de la maladie thromboembolique veineuse en médecine, 2009. ,
Les nouveaux anticoagulants dans la maladie thrombo-embolique veineuse, Revue des Maladies Respiratoires, vol.28, issue.8, pp.1008-1016, 2011. ,
DOI : 10.1016/j.rmr.2010.12.014
Am??liorations pharmacologiques apport??es par les nouveaux anticoagulants oraux, La Presse M??dicale, vol.42, issue.9, pp.1206-1212, 2013. ,
DOI : 10.1016/j.lpm.2013.06.008
Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin, Circulation: Cardiovascular Quality and Outcomes, vol.6, issue.5 ,
DOI : 10.1161/CIRCOUTCOMES.113.000192
« New Oral Anticoagulants for the Treatment of Venous Thromboembolism », Best Practice & Research, Clinical Haematology, vol.26, issue.2, pp.151-161, 2013. ,
Attlas d'anatomie humaine, pp.526-530, 2011. ,
Cardiovascular Physiology, Annual Review of Physiology, vol.43, issue.1, 2001. ,
DOI : 10.1146/annurev.ph.43.030181.002041
William Harvey découvre le mouvement circulaire du sang, in La Recherche, N° 400 septembre, p.42, 1628. ,
Cardiovascular physiology concepts, La pompe veineuse plantaire : Anatomie et hypothèses physiologiques, pp.9-18, 2005. ,
Gefässen Entzündung und septische Infektion, Gesammelte Abhandlungen zur wissenschaftlichen Medicin, pp.219-732 ,
Natural History of Venous Thromboembolism, 2003. ,
The Lancet 294, pp.7614-230, 1969. ,
The origin of deep vein thrombosis: a venographic study, The British Journal of Radiology, vol.44, issue.525, pp.525-653 ,
DOI : 10.1259/0007-1285-44-525-653
The mechanisms of canalisation in deep vein thrombosis, The Journal of Pathology, vol.40, issue.2, pp.153-165, 1973. ,
DOI : 10.1002/path.1711100207
Treatment of venous thromboembolic disease, Semin Thromb Hemost, vol.2, pp.291-331, 1976. ,
Syndrome post-thrombotique : la complication négligée de la maladie thromboembolique veineuse », Revue médicale suisse 372, pp.321-325, 2013. ,
Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort, The American Journal of Medicine, vol.126, issue.9, 2013. ,
DOI : 10.1016/j.amjmed.2013.02.024
Incidence of venous thromboembolism verified by necropsy over 30 years., BMJ, vol.302, issue.6778, pp.6778-709, 1991. ,
DOI : 10.1136/bmj.302.6778.709
« Thrombose veineuse profonde : épidemiologie, facteurs de risque acquis ». Annales de cardiologie et, pp.124-128, 2002. ,
DOI : 10.1016/s0003-3928(02)00083-5
Epidemiology and Risk Factors for Venous Thrombosis, Seminars in Hematology, vol.44, issue.2, pp.62-69, 2007. ,
DOI : 10.1053/j.seminhematol.2007.02.004
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis, New England Journal of Medicine, vol.334, issue.12, pp.759-62, 1996. ,
DOI : 10.1056/NEJM199603213341203
The Incidence of Thromboembolic Events in Surgically Treated Ankle Fracture, The Journal of Bone and Joint Surgery-American Volume, vol.94, issue.6, pp.502-506 ,
DOI : 10.2106/JBJS.J.01190
Epidemiology and Pathophysiology of Cancer-associated Thrombosis, British Journal of Cancer, vol.102, issue.1, 2010. ,
A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices, Journal of Internal Medicine, vol.91, issue.24, pp.168-176, 2006. ,
DOI : 10.1007/s11239-004-0208-6
URL : https://hal.archives-ouvertes.fr/hal-00281342
« Thromboprophylaxis in Non-surgical Patients: Who, When and How?, Haemostasis, vol.28 ,
Venous thromboembolism during pregnancy or postpartum: Findings from the RIETE Registry, Thrombosis and Haemostasis, vol.97, issue.2, pp.186-190, 2007. ,
DOI : 10.1160/TH06-11-0650
Venous Thrombosis: An Overview, VASA. Supplementum, vol.25, pp.1-28, 1988. ,
« [The treatment of deep venous thrombosis of the lower limbs], pp.35-1225, 1988. ,
« A Simple Clinical Model for the Diagnosis of Deep-vein Thrombosis Combined with ,
Value of assessment of pretest probability of deep-vein thrombosis in clinical management, The Lancet, vol.350, issue.9094, pp.9094-1795, 1997. ,
DOI : 10.1016/S0140-6736(97)08140-3
« Does This Patient Have Deep Vein Thrombosis?, JAMA: The Journal of the American Medical Association, vol.295, issue.2, 2006. ,
« Plasma Measurement of D-dimer as Diagnostic Aid in Suspected Venous Thromboembolism: An Overview, Thrombosis and Haemostasis, vol.71, issue.1, pp.1-6, 1994. ,
« Using an Age-dependent D-dimer Cut-off Value Increases the Number of Older Patients in Whom Deep Vein Thrombosis Can Be Safely Excluded, Haematologica, vol.97, p.10, 2012. ,
Clinical significance of a negative D-dimer level in patients with confirmed venous thromboembolism. Findings from the RIETE Registry, Journal of Thrombosis and Haemostasis, vol.340, issue.2, pp.407-410, 2011. ,
DOI : 10.1111/j.1538-7836.2010.04143.x
Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review, Journal of Thrombosis and Haemostasis, vol.349, issue.2, pp.296-304, 2007. ,
DOI : 10.1111/j.1538-7836.2007.02328.x
« Evaluation of D-dimer in the Diagnosis of Suspected Deep-vein Thrombosis, The New England Journal of Medicine, vol.349, pp.13-1227, 2003. ,
Noninvasive Diagnosis of Deep Venous Thrombosis, Annals of Internal Medicine, vol.128, issue.8, pp.663-677, 1998. ,
DOI : 10.7326/0003-4819-128-8-199804150-00011
Non-invasive diagnosis of venous thromboembolism in outpatients, The Lancet, vol.353, issue.9148, pp.190-195, 1999. ,
DOI : 10.1016/S0140-6736(98)05248-9
« Randomised Trial of Effect of Compression Stockings in Patients with Symptomatic Proximal-vein Thrombosis, Lancet, vol.34915, pp.9054-759, 1997. ,
Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome, Annals of Internal Medicine, vol.141, issue.4, pp.249-256, 2004. ,
DOI : 10.7326/0003-4819-141-4-200408170-00004
« Heparin and Low-molecular-weight Heparin: Mechanisms of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety, pp.489-510, 1998. ,
« The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, pp.204-233, 2004. ,
Dur??e optimale du traitement anticoagulant au d??cours d???une maladie veineuse thrombo-embolique, Journal des Maladies Vasculaires, vol.36, issue.1, pp.28-32, 2011. ,
DOI : 10.1016/S0398-0499(11)70005-1
The Novel Anticoagulants: Entering a New Era », Swiss Medical Weekly 139, pp.5-6 ,
Les nouveaux anticoagulants dans la maladie thrombo-embolique veineuse, Revue des Maladies Respiratoires, vol.28, issue.8, pp.1008-1016, 2011. ,
DOI : 10.1016/j.rmr.2010.12.014
Pharmacology of the new target-specific oral anticoagulants, Journal of Thrombosis and Thrombolysis, vol.160, issue.5, pp.133-140, 2013. ,
DOI : 10.1007/s11239-013-0929-5
« The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans », Drug Metabolism and Disposition: The Biological Fate of Chemicals 36, pp.386-399, 2008. ,
« In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans », Drug Metabolism and Disposition: The Biological Fate of Chemicals 37, pp.1046-1055, 2009. ,
« Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans », Drug Metabolism and Disposition: The Biological Fate of Chemicals 37, pp.74-81, 2009. ,
« In Vitro Study of the Anticoagulant Effects of Edoxaban and Its Effect on Thrombin Generation in Comparison to Fondaparinux, Thrombosis Research, vol.129, issue.4, pp.77-82, 2012. ,
Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment, The Journal of Clinical Pharmacology, vol.11, issue.6, pp.12-1411, 2008. ,
DOI : 10.1177/0091270008324179
A specific antidote for dabigatran: functional and structural characterization, Blood, vol.121, issue.18, pp.3554-3562, 2013. ,
DOI : 10.1182/blood-2012-11-468207
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa, Nature Medicine, vol.48, issue.4, pp.446-451, 2013. ,
DOI : 10.1038/nm.3102
« Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism, The New England Journal of Medicine, vol.361, pp.24-2342, 2009. ,
Oral Apixaban for the Treatment of Acute Venous Thromboembolism, New England Journal of Medicine, vol.369, issue.9, pp.799-808, 2013. ,
DOI : 10.1056/NEJMoa1302507
URL : https://hal.archives-ouvertes.fr/hal-00932477
Edoxaban Versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism, The New England Journal of Medicine, vol.369, pp.15-1406, 2013. ,
Evaluation du niveau de risque cardiovasculaire des médecins généraliste de la région PACA ,
« [New oral anticoagulants in primary care: The general practitioner's point of view], Presse médicale, pp.1267-1273, 1983. ,
Etudes de la prescription de nouveaux anticoagulants oraux dans l'acfa chez les médecins généralistes picard, Thèse de médecine faculté d'Amiens, 2013. ,
La Sécu victime d'un hold-up de 400 millions d'euros, 2013. ,
Les mirages des nouveaux anticoagulants. Florence Rosier, 2013. ,
Coumadine?? vs Pr??viscan????: comparaison du temps pass?? dans la fourchette th??rapeutique de l???INR chez un groupe de patients suivis ?? la clinique des anticoagulants de Toulouse, Journal des Maladies Vasculaires, vol.34, p.28, 2009. ,
DOI : 10.1016/j.jmv.2009.07.036
dabigatran (Pradaxa°), rivaroxaban (Xarelto°) : une place très restreinte en pratique, peu d'expérience clinique et pas d'antidote », Prescrire Décembre, 2013. ,
Pas d'antidote et peu d'expérience clinique», Prescrire, vol.33, issue.353, pp.202-206, 2013. ,